To confirm the suitability of the T2D mouse model, body weight and the levels of blood glucose, plasma AGEs, and plasma insulin were measured before and on days 14 and 21 after implementation of limb ischemia. The gene discussed is INS; the disease is type 2 diabetes mellitus.